The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998-2011

Jacob E Simmering, Fan Tang, Joseph E Cavanaugh, Linnea A Polgreen, Philip M Polgreen, Jacob E Simmering, Fan Tang, Joseph E Cavanaugh, Linnea A Polgreen, Philip M Polgreen

Abstract

Background: Outpatient therapies for urinary tract infections (UTIs) are becoming limited due to antimicrobial resistance. The purpose of this paper is to report how the incidence of hospitalizations for UTIs have varied over time in both men and women and across age groups. We also explore how the severity for UTI hospitalizations has changed and describe the seasonality of UTI hospitalizations.

Methods: Using the Nationwide Inpatient Sample, we compute a time-series of UTI incidence and subdivide the series by age and sex. We fit a collection of time-series models to explore how the trend and seasonal intensity varies by age and sex. We modeled changes in severity using regression with available confounders.

Results: In 2011, there were approximately 400000 hospitalizations for UTIs with an estimated cost of $2.8 billion. Incidence increased by 52% between 1998 and 2011. The rate of increase was larger among both women and older patients. We found that the seasonal intensity (summer peaks and winter troughs) increased over time among women while decreasing among men. For both men and women, seasonality decreased with advancing age. Relative to controls and adjusted for demographics, we found that costs among UTI patients grew more slowly, patients left the hospital earlier, and patients had lower odds of death.

Conclusions: Incidence of UTI hospitalization is increasing and is seasonal, peaking in the summer. However, the severity of UTI admissions seems to be decreasing, indicating that patients previously treated as outpatients may now be admitted to the hospital due to increasing antimicrobial resistance.

Keywords: healthcare costs; seasonality; time series; trends; urinary tract infections..

© The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Figures

Figure 1.
Figure 1.
Urinary tract infection (UTI) incidence and total cost of hospitalizations by sex, 1998–2011. Incidence is the number of cases per 10000 people in the community by sex, and real total costs are converted to costs using the Healthcare Cost and Utilization Project cost-to-charge ratio and are normalized to constant December 2011 dollars. Solid lines denote the male series, whereas dotted lines represent the female series.
Figure 2.
Figure 2.
Urinary tract infection (UTI) and pyelonephritis incidence, 1998–2011. Incidence is the number of cases per 10000 people by month.

References

    1. Nicolle LE. Epidemiology of urinary tract infections. Clin Microbiol Newsletter 2002; 24:135–40.
    1. Foxman B, Barlow R, D’Arcy H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10:509–15.
    1. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335:468–74.
    1. Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 2002; 34:1061–6.
    1. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329:1328–34.
    1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113:5S–13S.
    1. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52:e103–20.
    1. Karlowsky JA, Jones ME, Thornsberry C, et al. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents 2001; 18:121–7.
    1. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 2003; 22:49–52.
    1. Kahlmeter G; ECO.SENS An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51:69–76.
    1. Metlay JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 2003; 51:963–70.
    1. Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006; 27:468–75.
    1. Olson RP, Harrell LJ, Kaye KS. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections. Antimicrob Agents Chemother 2009; 53:1285–6.
    1. Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother 2012; 56:2181–3.
    1. Raz R, Chazan B, Kennes Y, et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002; 34:1165–9.
    1. Zilberberg MD, Shorr AF. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000–2009. Infect Control Hosp Epidemiol 2013; 34: 940–6.
    1. Anderson JE. Seasonality of symptomatic bacterial urinary infections in women. J Epidemiol Community Health 1983; 37:286–90.
    1. Stamm WE, McKevitt M, Roberts PL, White NJ. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991; 13:77–84.
    1. Perencevich EN, McGregor JC, Shardell M, et al. Summer Peaks in the incidences of Gram-negative bacterial infection among hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:1124–31.
    1. Falagas ME, Peppas G, Matthaiou DK, et al. Effect of meteorological variables on the incidence of lower urinary tract infections. Eur J Clin Microbiol Infect Dis 2009; 28:709–12.
    1. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Seasonal variation in Escherichia coli bloodstream infection: a population-based study. Clin Microbiol Infect 2009; 15:947–50.
    1. US Bureau of Labor Statistics. Consumer Price Index for All Urban Consumers: Medical Care (CPIMEDSL) Available at: Accessed 18 July 2016.
    1. Bhavan KP, Brown LS, Haley RW. Self-administered outpatient antimicrobial infusion by uninsured patients discharged from a safety-net hospital: a propensity-score-balanced retrospective cohort study. PLoS Med 2015; 12:e1001922.
    1. Rossignol L, Pelat C, Lambert B, et al. A method to assess seasonality of urinary tract infections based on medication sales and google trends. PLoS One 2013; 8:e76020.
    1. Hooton TM. Uncomplicated urinary tract infection. N Engl J Med 2012; 366:1028–37.
    1. Scholes D, Hooton TM, Roberts PL, et al. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005; 142:20–7.
    1. Falagas ME, Theocharis G, Spanos A, et al. Effect of meteorological variables on the incidence of respiratory tract infections. Respir Med 2008; 102:733–7.
    1. Fisman D. Seasonality of viral infections: mechanisms and unknowns. Clin Microbiol Infect 2012; 18:946–54.
    1. Fisman DN. Seasonality of infectious diseases. Annu Rev Public Health 2007; 28:127–43.
    1. Fisman DN, Lim S, Wellenius GA, et al. It’s not the heat, it’s the humidity: wet weather increases legionellosis risk in the greater Philadelphia metropolitan area. J Infect Dis 2005; 192:2066–73.
    1. Freeman JT, Anderson DJ, Sexton DJ. Seasonal peaks in Escherichia coli infections: possible explanations and implications. Clin Microbiol Infect 2009; 15:951–3.
    1. Schwab F, Gastmeier P, Meyer E. The warmer the weather, the more Gram-negative bacteria—impact of temperature on clinical isolates in intensive care units. PLoS One 2014; 9:e9115.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren